Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

848
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
848
Drug Discovery: Overview01:26

Drug Discovery: Overview

8.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.8K
Preclinical Development: Overview01:28

Preclinical Development: Overview

4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K
Drug Regulation01:25

Drug Regulation

1.8K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.8K
Prodrugs01:30

Prodrugs

2.9K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
2.9K
Clinical Trials: Overview01:11

Clinical Trials: Overview

3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patent highlights February-March 2024.

Pharmaceutical patent analyst·2025
Same author

Patent highlights June - July 2024.

Pharmaceutical patent analyst·2025
Same author

Patent highlights April-May 2024.

Pharmaceutical patent analyst·2025
Same author

Patent highlights December 2023-January 2024.

Pharmaceutical patent analyst·2025
Same author

Drug Repurposing Patent Applications January-March 2025.

Assay and drug development technologies·2025
Same author

Patent highlights June - July 2024.

Pharmaceutical patent analyst·2025
Same journal

Molecular Mechanisms and Optimization Strategies for the Impact of Antihypertensive, Lipid-Lowering, and Antidiabetic Drugs on Gut Microbiota.

Assay and drug development technologies·2026
Same journal

Identification of Broad-Spectrum Inhibitors Targeting Multiple Amyloidogenic Proteins Using Functional Group-Based Virtual Screening.

Assay and drug development technologies·2026
Same journal

Formulation, Characterization, and Biological Assessment of Embelin-Loaded Glycerosomes.

Assay and drug development technologies·2026
Same journal

Comprehensive Physicochemical Characterization and Release Kinetics of an Astaxanthin Nanoplex: Integrated <i>In Silico</i> and <i>In Vitro</i> Evaluation.

Assay and drug development technologies·2026
Same journal

Indolizine Compound Selection for HPV Anticancer Active Prediction Using CNN Classifier with ADME Descriptors.

Assay and drug development technologies·2026
Same journal

Ellagic Acid-Loaded Microsponges Impregnated Chitosan-Guar Gum Hydrogel for Wound Therapy: Investigation on Rheology, Antioxidant, and Antimicrobial Activities.

Assay and drug development technologies·2026
See all related articles

Related Experiment Video

Updated: Sep 13, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.7K

Drug Repurposing Patent Applications October-December 2024.

Hermann A M Mucke1

  • 1H.M. Pharma Consultancy, Wien, Austria.

Assay and Drug Development Technologies
|July 25, 2025
PubMed
Summary
This summary is machine-generated.

Drug repurposing patent applications show diverse global innovation. Novel therapeutic uses were identified for conditions including Parkinson's disease, Angelman syndrome, and schizophrenia, highlighting significant advancements in late 2024.

Keywords:
depressionhypothermiaophthalmologypainpatentsrare diseases

More Related Videos

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production
06:18

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Published on: August 18, 2023

2.8K
Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
08:36

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on: April 7, 2023

1.2K

Related Experiment Videos

Last Updated: Sep 13, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.7K
Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production
06:18

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Published on: August 18, 2023

2.8K
Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
08:36

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on: April 7, 2023

1.2K

Area of Science:

  • Pharmaceutical Sciences
  • Drug Discovery
  • Intellectual Property

Background:

  • Drug repurposing is a key strategy for developing new therapeutics.
  • Recent patent filings indicate a surge in innovation in this field.
  • Global interest in drug repurposing spans multiple continents and research institutions.

Purpose of the Study:

  • To review significant PCT patent applications in drug repurposing published in late 2024.
  • To highlight the diversity of applicants, therapeutic targets, and geographic representation.
  • To showcase novel drug repurposing strategies and potential treatments.

Main Methods:

  • Analysis of 17 PCT patent applications related to drug repurposing.
  • Selection based on significance of innovation.
  • Categorization by applicant, active agent, and geographic origin.

Main Results:

  • Diverse applicants from US, China, Japan, Germany, UK, Canada, Algeria, and Iceland.
  • Specific examples include entacapone for therapeutic hypothermia, sulindac for Angelman syndrome, and gliclazide for schizophrenia.
  • Demonstrated potential for treating neurodevelopmental disorders and neurological conditions.

Conclusions:

  • Late 2024 patent filings reveal a dynamic landscape of drug repurposing research.
  • Innovation is geographically widespread, with significant contributions from various international entities.
  • Identified repurposing candidates offer promising therapeutic avenues for challenging diseases.